NCT01839214View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Ulcerative Colitis
Interventions
DRUG

VB-201 160mg

DRUG

Placebo

Trial Locations (3)

Unknown

VBL Investigative Site, Sofia

VBL Investigative Site, Szombathely

VBL Investigative Site, Warsaw

All Listed Sponsors
lead

Vascular Biogenics Ltd. operating as VBL Therapeutics

INDUSTRY

NCT01839214 - A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis | Biotech Hunter | Biotech Hunter